packageNivolumab

nivolumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Nivolumab is an anti-PD-1 monoclonal antibody used to treat several cancers, including melanoma, lung, kidney, bladder, and head and neck cancers, Hodgkin lymphoma, and mesothelioma. It is widely used and authorised in the European Union, though one EU product has been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q7041828 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:nivolumab
ATC codes:L01FF01, L01XC17
DrugBank:DB09035
Wikidata:Q7041828
molar mass:143597 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown